EPULIS

EPULIS was reported 29 times

EPULIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Survival of Motor Neuron 2 Splicing Modifier [EPC] 1 0.0002
1 Vitamin D2 Analog [EPC] 1 0.0001
2 RNA Synthetase Inhibitor Antibacterial [EPC] 1 0.0001
3 Protease Inhibitor [EPC] 3 0.0001
4 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
5 Vitamin D Analog [EPC] 1 0.0001
6 Cytochrome P450 3A Inhibitor [EPC] 3 0.0000
7 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
8 Interleukin-17A Antagonist [EPC] 1 0.0000
9 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
10 Proteasome Inhibitor [EPC] 2 0.0000
11 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
12 Nitroimidazole Antimicrobial [EPC] 1 0.0000
13 Androgen Receptor Inhibitor [EPC] 1 0.0000
14 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
15 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
16 Aromatase Inhibitor [EPC] 1 0.0000
17 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
18 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
19 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
20 Opioid Agonist [EPC] 2 0.0000
21 Aldosterone Antagonist [EPC] 1 0.0000
22 Thalidomide Analog [EPC] 3 0.0000
23 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
24 RANK Ligand Inhibitor [EPC] 1 0.0000
25 Thiazide Diuretic [EPC] 1 0.0000
26 Vitamin D [EPC] 1 0.0000
27 beta-Adrenergic Blocker [EPC] 1 0.0000
28 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
29 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
30 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
31 Vitamin C [EPC] 1 0.0000
32 Insulin Analog [EPC] 1 0.0000
33 Loop Diuretic [EPC] 1 0.0000
34 Platelet Aggregation Inhibitor [EPC] 1 0.0000
35 Corticosteroid [EPC] 1 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000